Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - quetiapine fumarate, quantity: 115.142 mg (equivalent: quetiapine, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; lactose monohydrate; calcium hydrogen phosphate dihydrate; povidone; titanium dioxide; hypromellose; purified talc; macrogol 400 - quetiapine rbx tablets are indicated for: bipolar disorder = maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes = treatment of depressive episodes associated with bipolar disorder (see dosage and administration) = treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate schizophrenia = treatment of schizophrenia

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - quetiapine fumarate, quantity: 345.425 mg (equivalent: quetiapine, qty 300 mg) - tablet, film coated - excipient ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; sodium starch glycollate type a; microcrystalline cellulose; povidone; magnesium stearate; titanium dioxide; hypromellose; purified talc; macrogol 400 - quetiapine rbx tablets are indicated for: bipolar disorder = maintenance treatment of bipolar i disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes = treatment of depressive episodes associated with bipolar disorder (see dosage and administration) = treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate schizophrenia = treatment of schizophrenia

Israel - English - Ministry of Health

abic marketing ltd, israel - quetiapine as fumarate - film coated tablets - quetiapine as fumarate 25 mg - quetiapine - quetiapine - - indicated for the treatment of schizophrenia.- treatment of manic episodes associated with bipolar disorder.- treatment of major depressive episodes in bipolar disorders.

Israel - English - Ministry of Health

abic marketing ltd, israel - quetiapine as fumarate - film coated tablets - quetiapine as fumarate 100 mg - quetiapine - quetiapine - ttreatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

Israel - English - Ministry of Health

abic marketing ltd, israel - quetiapine as fumarate - film coated tablets - quetiapine as fumarate 200 mg - quetiapine - quetiapine - ttreatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

Israel - English - Ministry of Health

abic marketing ltd, israel - quetiapine as fumarate - film coated tablets - quetiapine as fumarate 300 mg - quetiapine - quetiapine - ttreatment of schizophrenia. treatment of manic episodes associated with bipolar disorder.treatment of major depressive episodes in bipolar disorders.

Israel - English - Ministry of Health

inovamed ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 50 mg - quetiapine - quetiapine inovamed sr is indicated for the treatment of schizophrenia. quetiapine inovamed sr is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine inovamed sr. quetiapine inovamed sr is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. quetiapine inovamed sr is indicated for the treatment of major depressive episodes in bipolar disorder. treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. quetiapine inovamed sr is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy. prior to initiating treatment, clinicians should consider the safety profile of quetiapine inovamed sr.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 150 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 200 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.

Israel - English - Ministry of Health

novartis israel ltd - quetiapine as fumarate - tablets prolonged release - quetiapine as fumarate 300 mg - quetiapine - quetiapine sandoz prt is indicated for the treatment of schizophrenia. quetiapine sandoz prt is effective in preventing relapse in stable schizophrenic patients who have been maintained on quetiapine sandoz prt. quetiapine sandoz prt is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder.treatment of acute mania associated with bipolar i disorder as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for the treatment of major depressive episodes in bipolar disorder. quetiapine sandoz prt is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment as monotherapy or in combination with lithium or sodium valproate. quetiapine sandoz prt is indicated for add-on treatment of major depressive episods in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy . prior to initiating treatment, clinicians should consider the safety profile of quetiapine sandoz prt.